CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma
Physician's Weekly,
THURSDAY, March 21, 2024 (HealthDay News) — For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (C…
THURSDAY, March 21, 2024 (HealthDay News) — For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (C…
When my uncle was diagnosed with glioblastoma, I knew he was on borrowed time. The deadliest form of brain cancer, it rapidly…
Findings from the INCIPIENT study, an early phase I open-label study among participants with recurrent glioblastoma treated…
Американские исследователи представили предварительные результаты первой фазы первых клинических испытаний CARv3-Т-лимфоцитов, вв…